Module

Estimating Benefit and Prognosis With Adjuvant Therapy for HER2-Positive Breast Cancer

Source: Adjuvant HER2-Positive Cancer: Integrating Prognostic Tools and Clinical Advances to Optimize Treatment

Estimating Benefit and Prognosis With Adjuvant Therapy for HER2-Positive Breast Cancer


Faculty:

  • Peter Ravdin, MD, PhD

CME CREDIT INFORMATION

Release Date: 12/11/07

Expiration Date: 12/10/08


Physicians: maximum of 1.0 AMA PRA Category 1 Credit(s)™

Status: Please log in to view status


Learning Objectives

Upon completion of this activity, participants should be able to:

  • Discuss variables and biomarkers involved in determining the prognosis of patients with breast cancer
  • Describe the effect of HER2 overexpresssion on the risk of breast cancer recurrence
  • Explain the use of risk estimation programs in assessing the benefit of adjuvant therapies for breast cancer
  • Describe the use of molecular assays as prognostic tools in the setting of breast cancer

Topics covered include:

  • Introduction
  • Variables and Biomarkers in Breast Cancer Risk Assessment and Prognosis
  • Adjuvant!—Development, Validation, and Limitations
  • The Effect of HER2 Overexpression on Risk of Relapse and Estimation of Benefit
  • The Use of Molecular Assays in Determining Prognosis
  • Conclusion
Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care Options, LLC.

Educational grant provided by:

Educational grants support only the CME-certified components of this program.